Genomic Characterization of Influenza B Victoria Lineage Viruses Circulating in Saudi Arabia During the 2024–2025 Season
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Nabeel Alzahrani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saud…. Hauptthemen laut MEDLINE: Influenza B virus, Genome, Viral, Influenza, Human. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Influenza B viruses contribute substantially to global morbidity and mortality, yet genomic data from the Middle East remain limited. We retrospectively performed whole‐genome sequencing of six influenza B virus‐positive residual nasopharyngeal specimens collected at King Abdulaziz Medical City, Riyadh, during the 2024–2025 season, including one fatal pediatric case, and described their genomic features alongside clinical outcomes. All six genomes belonged to the B/Victoria lineage and clustered within V1A.3a.2‐derived subclades circulating globally during 2024–2025. Five genomes, including the fatal pediatric case, were assigned to subclade C.5.6, whereas one non‐fatal case belonged to C.5.7. The Saudi sequences were interspersed among contemporaneous reference strains from Europe, Asia, and North America, without evidence of a distinct local lineage. The fatal isolate did not occupy a distinct phylogenetic position and contained none of the screened virulence‐associated markers, including the neuraminidase N342K substitution. These genomes provide regional surveillance data from an underrepresented setting. Given the small sample size and inclusion of a single fatal case, the findings are descriptive and do not permit inference regarding genomic determinants of disease severity. Larger studies integrating viral genomic, clinical, and host data are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
- King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
- Division of Microbiology, Department of Pathology and Laboratory Medicine, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
- Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
- Laboratory of Infectious Disease Epidemiology, Biological and Environmental Science and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
ORCID-Profile: Nabeel Alzahrani, Omniya Fallatah, Samer Zakri, Turki Abujamel, Anwar M Hashem, Sameera Al Johani
Zitieren
APA
Alzahrani, N., Alyami, R., BuAli, Z., Fallatah, O., Zakri, S., Alnujaim, A., Bosaeed, M., Abujamel, T., Hashem, A. M., & Johani, S. A. (2026). Genomic Characterization of Influenza B Victoria Lineage Viruses Circulating in Saudi Arabia During the 2024–2025 Season. Journal of Medical Virology. https://doi.org/10.1002/jmv.71128
Vancouver
Alzahrani N, Alyami R, BuAli Z, Fallatah O, Zakri S, Alnujaim A, et al. Genomic Characterization of Influenza B Victoria Lineage Viruses Circulating in Saudi Arabia During the 2024–2025 Season. Journal of Medical Virology. 2026. doi:10.1002/jmv.71128
BibTeX
@article{Alzahrani2026,
author = {Alzahrani, Nabeel and Alyami, Rfeef and BuAli, Zainab and Fallatah, Omniya and Zakri, Samer and Alnujaim, Ahmed and Bosaeed, Mohammad and Abujamel, Turki and Hashem, Anwar M and Johani, Sameera Al},
title = {Genomic Characterization of Influenza B Victoria Lineage Viruses Circulating in Saudi Arabia During the 2024–2025 Season},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71128}
}
EUVIMED